About the Company
PRA is one of the world's leading global contract research organizations by revenue, providing outsourced clinical development and data solution services to the biotechnology and pharmaceutical industries. PRA's global clinical development platform includes more than 70 offices across North America, Europe, Asia, Latin America, South Africa, Australia and the Middle East and more than 18,100 employees worldwide. Since 2000, PRA has participated in approximately 4,200 clinical trials worldwide. In addition, PRA has participated in the pivotal or supportive trials that led to U.S. Food and Drug Administration or international regulatory approval of more than 100 drugs.
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology
Employees
17000
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $PRAH News
Regulatory Affairs Outsourcing Market To Reach USD 13.1 Billion By 2032 | DataHorizzon Research
The regulatory affair outsourcing market size was valued at USD 6.6 Billion in 2023 and is expected to reach a market size of ...
Analysts Are Bullish on Top Healthcare Stocks: Reviva Pharmaceuticals Holdings (RVPH), Roivant Sciences (ROIV)
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Reviva Pharmaceuticals Holdings (RVPH – ...
Loading the latest forecasts...